DIA
PFE icon

Denver Investment Advisors’s Pfizer PFE Stock Holding History

Denver Investment Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		$18M Buy
535,225
+3,030
+0.6% +$104K 0.95% 26
2017
Q4 		$18.3M Sell
532,195
-8,749
-2% -$298K 0.91% 23
2017
Q3 		$18.3M Buy
540,944
+1,574
+0.3% +$50.6K 0.9% 26
2017
Q2 		$17.2M Buy
539,370
+4,082
+0.8% +$129K 0.76% 45
2017
Q1 		$17.4M Buy
535,288
+8,222
+2% +$259K 0.78% 39
2016
Q4 		$16.2M Buy
527,066
+24,524
+5% +$749K 0.69% 50
2016
Q3 		$16.1M Buy
502,542
+5,114
+1% +$171K 0.71% 49
2016
Q2 		$16.6M Sell
497,428
-33,763
-6% -$1.08M 0.75% 34
2016
Q1 		$14.9M Sell
531,191
-37,023
-7% -$1.06M 0.66% 46
2015
Q4 		$17.4M Buy
568,214
+53,517
+10% +$1.68M 0.79% 30
2015
Q3 		$15.3M Buy
514,697
+13,340
+3% +$428K 0.67% 52
2015
Q2 		$15.9M Sell
501,357
-6,536
-1% -$213K 0.59% 61
2015
Q1 		$16.8M Buy
507,893
+12,770
+3% +$406K 0.55% 63
2014
Q4 		$14.6M Buy
495,123
+11,461
+2% +$329K 0.47% 71
2014
Q3 		$13.6M Buy
483,662
+2,132
+0.4% +$59.8K 0.44% 70
2014
Q2 		$13.6M Sell
481,530
-742
-0.2% -$21.2K 0.41% 69
2014
Q1 		$14.7M Sell
482,272
-8,235
-2% -$246K 0.43% 72
2013
Q4 		$14.3K Sell
490,507
-3,580
-0.7% -$104K 0.4% 78
2013
Q3 		$13.5M Buy
494,087
+10,912
+2% +$297K 0.29% 118
2013
Q2 		$12.8M Buy
+483,175
New +$13.4M 0.29% 112

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Denver Investment Advisors's PFE Position: Q1 2018 in Review

Denver Investment Advisors increased its Pfizer (PFE) stake by 0.57% in Q1 2018, buying an estimated $104K and bringing the position to 535,225 shares worth $18M. The position accounts for 0.95% of the portfolio, ranked #26.

Denver Investment Advisors first reported a position in PFE in Q2 2013 and has held it in 20 quarters since. The position peaked at $18.3M in Q3 2017. 2,230 funds tracked by Wall St. Rank hold PFE as of Q1 2018.

  • Denver Investment Advisors held 535,225 shares of Pfizer worth $18M as of Q1 2018.
  • Denver Investment Advisors bought 3,030 Pfizer shares in Q1 2018, an estimated $104K.
  • Pfizer made up 0.95% of Denver Investment Advisors's portfolio in Q1 2018, its #26 holding.
  • Denver Investment Advisors first reported a position in Pfizer in Q2 2013 and has held it in 20 quarters since.
  • Denver Investment Advisors's Pfizer position peaked at $18.3M in Q3 2017.
  • 2,230 funds tracked by Wall St. Rank held Pfizer as of Q1 2018.

Based on Denver Investment Advisors's 13F filing for Q1 2018, filed 10 May 2018.